dalarelin

Known as: Ala(6)-des-Gly(10)-NHEt-GnRH 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2016
01219992016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVES Gonadoliberin (GnRH) analogs may be expected to indirectly modify growth hormone (GH) total concentration and its 24-h… (More)
Is this relevant?
2016
2016
Although many synthetic gonadoliberin analogs have been developed, only a few of them, including buserelin, were introduced into… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
Is this relevant?
2014
2014
OBJECTIVES Certain therapies with the use of analogs of gonadotropin-releasing hormone (GnRH, gonadoliberin) aim at achieving the… (More)
Is this relevant?
2012
2012
BACKGROUND Long-term treatment with gonadoliberin analogs is used to block the hypothalamic-pituitary-gonadal axis. The use of… (More)
Is this relevant?
2003
2003
The preparation and properties of low soluble, suspended Zn(II) complexes containing the selected peptides: tyroliberin (TRH… (More)
Is this relevant?
2002
2002
A complex coacervation method was used to prepare microcapsules containing 74.8 +/- 1.5% of the 125I labelled dalarelin… (More)
Is this relevant?
2000
2000
The dynamics of concentration changes for dalarelin in the blood as well as in organs and tissues at different times from its… (More)
Is this relevant?
1999
1999
125I-marked dalarelin (a modified analogue of GnRH) or GnRH (gonadotropin-releasing hormone) were administered to the tested rats… (More)
Is this relevant?